Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILCPA > Volume 66 > Synthesis and Characterization of Some Novel...
< Back to Volume

Synthesis and Characterization of Some Novel Coumarin Based 2-Pyridone Heterocycles with their Broad Spectrum Antimicrobial Potency

Full Text PDF

Abstract:

The synthesis of a novel series of 6-((arylidene) amino)-2-oxo-1-((1-(2-oxo-2H-chromen-3-yl) ethylidene) amino)-4-phenyl-1,2-dihydropyridine-3,5-dicarbonitriles 4a-o were synthesized and structures of compounds have been elucidated by IR, 1H NMR, 13C NMR and mass spectral data. Antimicrobial activity was measured against certain strains of bacteria and fungi by serial broth dilution. Evaluation of antimicrobial activity shown that the compounds (4g, 4j, 4k and 4o) were found to be most active against selected bacterial strains and compounds (4d, 4m and 4n) were found to be most active against selected fungal strains.

Info:

Periodical:
International Letters of Chemistry, Physics and Astronomy (Volume 66)
Pages:
1-12
Citation:
N. C. Desai and T. J. Karkar, "Synthesis and Characterization of Some Novel Coumarin Based 2-Pyridone Heterocycles with their Broad Spectrum Antimicrobial Potency", International Letters of Chemistry, Physics and Astronomy, Vol. 66, pp. 1-12, 2016
Online since:
May 2016
Export:
Distribution:
References:

[1] V.K. Vladimir, G.B. Alicia, Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation, Eur. J. Med. Chem. 44 (2009) 3091-3113.

[2] R.O. Kennedy, R.D. Thomas, Coumarins: Biology, Applications and Mode of Action, Wiley & Sons, Chichester, (1997).

[3] M. Kawase, B. Varu, A. Shah, N. Motohashi, S. Tani, S. Saito, S. Debnath, S. Mahapatra, S.G. Dastidar, A.N. Chakrabarty, Antimicrobial activity of new coumarin derivatives, Arzneimittelforschung. 51 (2001) 67-71.

[4] K.B. Vyas, K.S. Mimavat, G.R. Jani, M.V. Hathi, Synthesis and antimicrobial activity of coumarin derivatives metal complex; An in vitro evaluation, Orbital. 1 (2009) 183-192.

[5] S. Bairagi, A. Bhosale, M.N. Deodhar, Design, Synthesis and Evaluation of Schiff's Bases of 4-Chloro-3-coumarin aldehyde as Antimicrobial Agents, E-J. Chem. 6 (2009) 759-762.

[6] S.E. Lopez, M.E. Rosales, C.E. Canelon, E.A. Valverode, R.C. Narvaez, J.E. Charris, F.A. Giannini, R.D. Enriz, M. Carrasco, S. Zacchino, Synthesis and preliminary cytotoxic and antifungal evaluation of some 6-n, n-dialkyl 2-aryl-4(3h)-quinazolinone derivatives, Hetrocycl. Commun. 7 (2000).

[7] K.M. Khan, S.S. Zafar, Z.K. Muhammad, Zia-Ullah, C.M. Iqbal, Atta-ur-Rahman, P. Shahnaz, H.C. Zahid, T.S. Claudiu, Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity, Enzyme Inhib. Med. Chem. 19 (2004) 373-379.

[8] Y. Bansal, P. Sethi, G. Bansal, Coumarin: a potential nucleus for anti-inflammatory molecules, Med. Chem. Res. 22 (2013) 3049-3060.

[9] K.C. Fylaktakidou, D.J. Hadjipavlou-Litina, K.E. Litinas, D.N. Nicolaides, Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities, Curr. Pharm. Des. 10 (2004) 3813-3833.

[10] M.A. Musa, J.S. Cooperwood, M.O.F. Khan, A review of coumarin derivatives in pharmacotherapy of breast cancer, Curr. Med. Chem. 15 (2008) 2664-2679.

[11] C. Kontogiorgis, A. Detsi, D. Hadjipavlou-Litina, Coumarin-based drugs: a patent review, Expert Opin. Ther. Patents. 22 (2012) 437-454.

[12] P.O. Patil, S.B. Bari, S.D. Firke, P.K. Deshmukh, S.T. Donda, D.A. Patil, A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease, Bioorg. Med. Chem. 21 (2013).

[13] S.V. Dekic, V.S. Dekic, B.R. Dekic, M.S. Dekic, Synthesis of new condensed and cyclized coumarin derivatives, Chemical Papers. 61 (2007) 233-235.

[14] W.B. Choi, I.N. Houpis, H.R.O. Churchill, A. Molina, J.E. Lynch, R.P. Volante, P.J. Reider, A.O. King, A practical synthesis of the 5-chloromethyl-furo[2, 3-b]pyridine pharmacophores, Tetrahedron Lett. 36 (1995) 4571-4574.

[15] M. Bhupathy, D.A. Conlon, K.M. Wells, J.R. Nelson, P.J. Reider, K. Rossen, J.W. Sager, R.P. Volante, B.D. Dorsey, J.M. Hoffman, S.A. Joseph, S.L.J. McDaniel, A practical synthesis of 5-(chloromethyl)furo[2, 3-b]pyridine, a key intermediate for the HIV protease inhibitor, Heterocycl. Chem. 32 (1995).

[16] C.O. Kappe, T. Kappe, Synthesis of substituted 3-pyridinecarbonitriles with potential biological activity, Monatsh. Chem. 120 (1989) 1095-1100.

[17] G. Ozturk, D.D. Erol, T. Uzbay, M.D. Aytemir, Synthesis of 4(1H)-pyridinone derivatives and investigation of analgesic and anti-inflammatory activities, Farmaco. 56 (2001) 251-256.

[18] A. Abadi, O. Al-Deeb, A. Al-Afify, H. El-Kashef, Synthesis of 4-alkyl (aryl)-6-aryl-3-cyano-2(1H)-pyridinones and their 2-imino isosteres as nonsteroidal cardiotonic agents, Farmaco. 54 (1999) 195-201.

[19] P. Storck, A. Aubertin, D.S. Grierson, Tosylation/mesylation of 4-hydroxy-3-nitro-2-pyridinones as an activation step in the construction of dihydropyrido [3, 4b] benzo [f] [1, 4]thiazepin-1-one based anti-HIV agents, Tetrahedron Lett. 46 (2005).

[20] A. Evidente, M. Fiore, G. Bruno, L. Sparapano, A. Motta, Chemical and biological characterisation of sapinopyridione, a phytotoxic 3, 3, 6-trisubstituted-2, 4-pyridione produced by Sphaeropsis sapinea, a toxigenic pathogen of native and exotic conifers and its derivatives, Phytochemistry. 67 (2006).

[21] M.T. Cocco, C. Congiu, V. Onnis, New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity, Eur. J. Med. Chem. 38 (2003) 37-47.

[22] Q. Li, L.A. Mitscher, L.L. Shen, The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors, Med. Res. Rev. 20 (2000) 231-293.

[23] L.A. Mitscher, Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents, Chem. Rev. 105 (2005) 559-592.

[24] N.C. Desai, N. Bhatt, A. Dodiya, T. Karkar, B. Patel, M. Bhatt, Synthesis, characterization and antimicrobial screening of thiazole based 1, 3, 4-oxadiazoles heterocycles, Res. Chem. Intermed. (2015).

[25] N.C. Desai, N.R. Shihory, G.M. Kotadiya, P. Desai, Synthesis, antibacterial and antitubercular activities of benzimidazole bearing substituted 2-pyridone motifs, Eur. J. Med. Chem. 82 (2014) 480-489.

[26] N.C. Desai, N. Shihory, M. Bhatt, B. Patel, T. Karkar, Studies on antimicrobial evaluation of some 1-(1-(1h-benzo[d]imidazol-2-yl)ethylidene)amino)-6-(arylidene) amino)-2-oxo-4-phenyl-1, 2-dihydropyridine-3, 5-dicarbonitriles, Synth. Commun. 45 (2015).

[27] National committee for clinical laboratory, Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically approved standard, third ed. NCCLS Publication M7-A3, Villanova, PA, (1993).

[28] National committee for clinical laboratory standards, Reference Method for Broth Dilution Antifungal Testing of Yeasts, Proposed Standard, NCCLS Document M27-P; Villanova, PA, (1992).

[29] N.C. Desai, V.V. Joshi, K.M. Rajpara, H.V. Vaghani, H.M. Satodiya, Facile synthesis of novel fluorine containing pyrazolebased thiazole derivatives and evaluation of antimicrobial activity, J. Fluorine Chem. 142 (2012) 67-78.

[30] N.C. Desai, K.M. Rajpara, V.V. Joshi, Synthesis and characterization of some new quinoline based derivatives endowed with broad spectrum antimicrobial potency, Bioorg. Med. Chem. Lett. 22 (2012) 6871- 6875.

Show More Hide
Cited By:
This article has no citations.